UBS Group AG - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 147 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,291,113
+871.2%
258,229
+841.9%
0.00%
Q2 2023$544,776
-72.6%
27,417
-76.4%
0.00%
-100.0%
Q1 2023$1,989,718
-65.6%
116,154
-60.7%
0.00%
-50.0%
Q4 2022$5,778,258
+273.5%
295,261
+204.7%
0.00%
+100.0%
Q3 2022$1,547,000
+68.3%
96,903
+45.1%
0.00%
Q2 2022$919,000
-66.7%
66,787
-61.7%
0.00%
-100.0%
Q1 2022$2,763,000
-10.1%
174,197
+23.8%
0.00%0.0%
Q4 2021$3,072,000
+7.2%
140,732
+46.7%
0.00%0.0%
Q3 2021$2,867,000
+431.9%
95,903
+688.6%
0.00%
Q2 2021$539,000
-83.6%
12,161
-83.6%
0.00%
-100.0%
Q1 2021$3,293,000
+30.1%
74,213
+60.8%
0.00%0.0%
Q4 2020$2,532,000
+449.2%
46,165
+128.8%
0.00%
Q3 2020$461,000
+620.3%
20,174
+561.9%
0.00%
Q2 2020$64,000
-84.9%
3,048
-90.0%
0.00%
Q1 2020$425,000
-66.7%
30,408
-45.8%
0.00%
Q4 2019$1,277,000
+109.3%
56,114
+7.2%
0.00%
Q3 2019$610,000
+626.2%
52,351
+839.5%
0.00%
Q2 2019$84,0005,572
+55620.0%
0.00%
Q1 2019$0
-100.0%
10
-99.9%
0.00%
Q4 2018$267,000
+117.1%
18,024
+259.4%
0.00%
Q3 2018$123,000
+73.2%
5,015
+37.8%
0.00%
Q2 2018$71,000
+144.8%
3,639
+130.6%
0.00%
Q1 2018$29,0001,5780.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders